$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO
7011
Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Meta-Analysis
Asian Pac J Cancer Prev, 14 (11), 7011-7016
Introduction
Parasitic diseases associated with cancer remain common and widespread in tropical countries. In Thailand, OLYHUÁXNHLQIHFWLRQZLWKOpisthorchis viverrini remains an important public health problem due to the traditional KXPDQKDELWRIHDWLQJUDZÀVK7KHHDWLQJRIUDZÀVKDQG
FXOWXUDOSRSXODUGLVKHVPDGHZLWKSDUWLDOO\FRRNHGRUUDZ
ÀVKZKLFKPD\FRQWDLQWKHLQIHFWLYHVWDJHPHWDFHUFDULDH RI O viverrini, has been practised in the northeastern UHJLRQZKHUHDVDFRQVHTXHQFHWKHKLJKHVWSUHYDOHQFH
RI O viverrini LQIHFWLRQ DQG LQFLGHQFH RI VXEVHTXHQW
FKRODQJLRFDUFLQRPD KDYH EHHQ REVHUYHG 6ULSD HW DO
.DHZSLWRRQHWDO*UXQG\HWDO7KH
SUREOHPLVHQGHPLFLQWKH0HNRQJUHJLRQ,Q7KDLODQG
DQGWKH/DR3HRSOH·V'HPRFUDWLF5HSXEOLF/DRV3'5
PDQ\SHRSOHDUHLQIHFWHGZLWKWKHOLYHUÁXNHO viverrini, QDPHO\HLJKWPLOOLRQ7KDLDQGWZRPLOOLRQLQ/DRV3'5
$SSUR[LPDWHO\RI7KDLFDVHVRFFXULQWKHQRUWKHUQ
DQGQRUWKHDVWHUQUHJLRQVRI7KDLODQG6LWKLWKDZRUQDQG
1Cancer Unit, Srinagarind Hospital, 2Department of Biostatistics and Demography, Faculty of Public Health, 3Department of Surgery, Faculty of Medicine, Khon Kaen University, Thailand *For correspondence: joevajara@gmail.com
Abstract
Background: The liver fluke, Opisthorchis viverrini, and the associated incidence of subsequent cholangiocarcinoma (CCA) are still a public health problem in Thailand, and praziquantel (PZQ) remains the antihelminthic drug of choice for treatment. Evidence in hamsters shows that repeated infection and PZQ treatments could increase the risk of CCA. However, the existing evidence in humans is inconclusive regarding increased risk of CCA with frequency of PZQ intake. Objectives: To investigate the relationship between number of repeated PZQ treatments and CCA in patients with O viverrini infection. Materials and Methods: The reviewed studies were searched in EMBASE, MEDLINE, ProQuest, PubMed and SCOPUS from inception to October,
XVLQJSUHVSHFLÀHGNH\ZRUGV7KHULVNRIELDV52%RILQFOXGHGVWXGLHVZDVLQGHSHQGHQWO\DVVHVVHGE\WZR
UHYLHZHUVXVLQJDTXDOLW\VFDOHIURPWKH1HZFDVWOH2WWDZD6FDOH1265LVNHIIHFWRI3=4ZDVHVWLPDWHGDVD
SRROHGRGGVUDWLR25ZLWKLWVFRQÀGHQFHLQWHUYDO&,LQWKHUDQGRPHIIHFWVPRGHOXVLQJ'HU6LPRQLDQ
and Laird’s estimator. 5HVXOWV Three studies involving 637 patients were included. Based on the random effects model performed in two included studies of 237 patients, the association between PZQ treatments and CCA was QRWVWDWLVWLFDOVLJQLÀFDQWZLWKDSRROHG25RI&,WRConclusions: The present systematic review and meta-analysis provides inconclusive evidence of risk effect of PZQ on increasing the risk of CCA and VLJQLÀFDQWPHWKRGRORJLFDOOLPLWDWLRQV)XUWKHUUHVHDUFKLVXUJHQWO\QHHGHGWRDGGUHVVWKHVKRUWFRPLQJVIRXQG
LQWKLVUHYLHZHVSHFLDOO\WKHUHTXLUHPHQWIRUKLVWRORJLFDOFRQÀUPDWLRQ
Keywords: &KRODQJLRFDUFLQRPDOpisthorchis viverriniUHSHDWHGSUD]LTXDQWHOWUHDWPHQWVV\VWHPDWLFUHYLHZ
5(6($5&+$57,&/(
Association between Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Systematic 5HYLHZDQG0HWD$QDO\VLV
Supot Kamsa-ard
1, Malinee Laopaiboon
2, Vor Luvira
3, Vajarabhongsa Bhudhisawasdi
3*
+DVZHOO(ONLQV6ULSDHWDO
)RU 7KDL SHRSOH WKH DJHVWDQGDUGL]HG UDWH $65 RIOLYHUDQGELOHGXFWFDQFHUVLVEHWZHHQDQG
SHU SHRSOH LQ PDOHV DQG EHWZHHQ DQG
SHU LQ IHPDOHV &&$ KDV EHHQ GHWHFWHG
DV WKH PRVW FRPPRQ KLVWRORJLFDO W\SH DFFRXQWLQJ IRU
EHWZHHQDQGRIDOOSULPDU\OLYHUFDQFHUV
9DWDQDVDSW HW DO 'HHUDVDPHH HW DO
6ULSOXQJ HW DO .KXKDSUHPD HW DO
7KH DYHUDJH SUHYDOHQFH RI OLYHU ÁXNH LQIHFWLRQ
caused by O viverriniKDVEHHQUHSRUWHGDVRIWKH
7KDL SRSXODWLRQ -RQJVXNVXQWLJXO EXW LW ZDV
distributed predominantly in the north and northeast -RQJVXNVXQWLJXO6LWKLWKDZRUQDQG+DVZHOO(ONLQV
/LWWOHHYLGHQFHRIWKHULVNIDFWRUVIRU&&$LVDYDLODEOH
DQGPRVWVWXGLHVKDYHIRFXVHGRQWKHUROHRIO viverrini LQIHFWLRQLQWKHVXEVHTXHQWGHYHORSPHQWRI&&$WKDWLV
WKHDUHDVZLWKDKLJKLQFLGHQFHRI&&$VKRZKLJK29
LQWHQVLWLHV7KHRGGVUDWLRVRIO viverriniLQIHFWLRQKDYH
$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO
7012
UDQJHGIURPWR3DUNLQHWDO+RQMRHWDO
3RRPSKDNZDHQHWDO,QDSUHYLRXVVWXG\
UHSRUWLQJSUHYDOHQFHRGGVUDWLRV325WKHOLJKWLQIHFWLRQ
JURXSZDVDSSUR[LPDWHO\WLPHVPRUHOLNHO\WRKDYH
&&$WKDQWKHQRQLQIHFWLRQJURXS&,WR ZKLOH WKH PRGHUDWH LQIHFWLRQ JURXS ZDV DSSUR[LPDWHO\
WLPHVPRUHOLNHO\WRKDYH&&$WKDQWKHQRQLQIHFWLRQ
JURXS &, WR DQG WKH KHDY\ LQIHFWLRQ
JURXSZDVDSSUR[LPDWHO\WLPHVPRUHOLNHO\WRKDYH
&&$WKDQWKHQRQLQIHFWLRQJURXS&,WR +DVZHOO(ONLQV HW DO ,Q DGGLWLRQ WR KXPDQ
HSLGHPLRORJLFDO VWXGLHV H[SHULPHQWV LQ KDPVWHUV KDYH
also shown that O viverriniLQIHFWLRQLVDVVRFLDWHGZLWK
&&$%KDPDUDSUDYDWLDQG9LUUDQXYDWWL7KDPDYLW
HWDO6ULSDHWDO6LWKLWKDZRUQ
3UD]LTXDQWHO 3=4 LV NQRZQ DV WKH DQWLKHOPLQWKLF
GUXJRIFKRLFHWRWUHDWO viverriniLQIHFWLRQDQGLWSURYLGHV
HIIHFWLYH FKHPRWKHUDS\ :+2 +RZHYHU D
SUHYLRXVVWXG\KDVIRXQGWKDWUDSLGUHLQIHFWLRQFDQRFFXU
DIWHUVXFFHVVIXO3=4WUHDWPHQWV8SDWKDPHWDO
3HRSOH HQMR\ HDWLQJ UDZ XQGHUFRRNHG RU LQDGHTXDWHO\
IHUPHQWHGIUHVKZDWHUÀVKDQGEHFDXVHWKH\DUHDZDUHWKDW
3=4LVDQHIIHFWLYHWUHDWPHQWWKH\UHWXUQWRHDWLQJFXOWXUDO
GLVKHV ZKLFK DUH OLNHO\ WR OHDG WR D IXUWKHU O viverrini LQIHFWLRQ 0DQ\ NQRZ WKDW LI WKH\ DUH UHLQIHFWHG WKH\
FDQDJDLQREWDLQWUHDWPHQWZLWK3=4DQGVRWKHF\FOHLV
SHUSHWXDWHG3UHYLRXVVWXGLHVLQKDPVWHUVLQIHFWHGZLWK
O viverrini UHSRUWHG WKDW UHSHDWHG LQIHFWLRQ DQG 3=4
WUHDWPHQWVFDQLQFUHDVHWKHULVNRI&&$3LQODRUHWDO
&KDURHQVXNHWDO+RZHYHUWKHIHZ
available studies in humans have shown unclear evidence RIDQLQFUHDVHGULVNRI&&$ZLWKLQFUHDVHGIUHTXHQF\RI
3=4LQWDNH&KHUQUXQJURM$V\VWHPDWLFUHYLHZ
RI WKH FXUUHQWO\ DYDLODEOH HYLGHQFH ZDV SHUIRUPHG WR
LQYHVWLJDWHWKHUHODWLRQVKLSEHWZHHQQXPEHURIUHSHDWHG
3=4 WUHDWPHQWV DQG &&$ LQ SDWLHQWV ZLWK O viverrini LQIHFWLRQV
Materials and Methods
Types of studies
6WXGLHV ZHUH VHOHFWHG LI WKH\ XVHG DQ\ DQDO\WLFDO
GHVLJQ VXFK DV FDVHFRQWURO PDWFKHG FDVHFRQWURO
QHVWHGFDVHFRQWUROFRKRUWDQGFURVVVHFWLRQDOGHVLJQVWR
LQYHVWLJDWHWKHDVVRFLDWLRQEHWZHHQ3=4WUHDWPHQWVDQG
CCA.
Selection of studied
6FUHHQV VKRZLQJ WKH WLWOH DEVWUDFW DQG ÀQDOO\ WKH
IXOO WH[W RI SXEOLFDWLRQV ZHUH LQGHSHQGHQWO\ HYDOXDWHG
E\WZRUHVHDUFKHUV6XSRW.DPVDDUG6.DQG0DOLQHH
/DRSDLERRQ0/'LVDJUHHPHQWZDVUHVROYHGWKURXJK
GLVFXVVLRQ ZLWK D WKLUG UHVHDUFKHU 9DMDUDEKRQJVD
%KXGKLVDZDVGL9% Exposure
7KHH[SRVXUHRILQWHUHVWZDVUHSHDWHGWUHDWPHQWZLWK
3=47KHIUHTXHQF\RI3=4WUHDWPHQWZDVFDWHJRUL]HG
LQWRIRXUGLIIHUHQWJURXSVQHYHUXVHGXVHGRQFHXVHG
WZLFHDQGXVHGPRUHWKDQWZLFH&KHUQUXQJURM
Outcome
7KHRXWFRPHZDV&&$&KRODQJLRFDUFLQRPD&&$ is a primary liver cancer, which arises in the epithelial FHOOVOLQLQJWKHLQWUDKHSDWLFDQGH[WUDKHSDWLFELOHGXFWV
EXWZKLFKGRHVQRWLQFOXGHPDOLJQDQFLHVRIWKHJDOOEODGGHU
RUDPSXOODRIYDWHU%KXGKLVDZDVGLHWDO
Literature research
,QDGGLWLRQWRKDQGVHDUFKLQJWKHIROORZLQJGDWDEDVHV
ZHUH VHDUFKHG ZLWKRXW ODQJXDJH UHVWULFWLRQ (0%$6(
0('/,1(3UR4XHVW3XE0HGDQG6&2386
6HDUFK WHUPV ZHUH XVHG LQ FRPELQDWLRQ DQG
FRYHUHG WKH QDPHV DQG V\QRQ\PV RI ´SUD]LTXDQWHOµ
´FKRODQJLRFDUFLQRPDµ ´FDQFHUµ ´ULVN IDFWRUµ DQG
´Opisthorchis viverriniµ7KHPRUHGHWDLOHGWHUPVXVHG
ZHUHDVIROORZVIRU´SUD]LTXDQWHOµWKHVHZHUH2SWLFLGH
3UDTXDQWHO 3UDVLNRQ 3UD]LWH DQG :RUPLFLGH IRU
´FKRODQJLRFDUFLQRPDµLQWUDKHSDWLFELOHGXFWVLQWUDKHSDWLF
bile duct carcinoma, intrahepatic bile duct cancers, bile duct adenocarcinoma, bile duct cystadenocarcinoma, bile GXFWFDQFHU.ODWVNLQ·VWXPRUSHULKLODUELOHGXFWFDQFHUV
KLODU ELOH GXFW FDQFHUV DQG GLVWDO ELOH GXFW FDQFHUV IRU
´FDQFHUµ WXPRUV PDOLJQDQF\ DQG FDUFLQRPD IRU
´ULVN IDFWRUµ ULVN DVVRFLDWLRQ UHODWLRQVKLS UHODWLRQ
FRUUHODWLRQFRQQHFWLRQDQG OLQN DQG IRU ´Opisthorchis viverriniµOLYHUÁXNHDQGO viverrini)LJXUHLVDÁRZ
GLDJUDPVKRZLQJWKHDUWLFOHVHOHFWLRQSURFHVV
Study inclusion/exclusion criteria
7KH LQFOXVLRQ FULWHULD IRU WKH VHOHFWLRQ RI SULPDU\
VWXGLHV ZHUH DV IROORZV i WKH DUWLFOH LQYHVWLJDWHG WKH
DVVRFLDWLRQ EHWZHHQ IUHTXHQF\ RI 3=4 WUHDWPHQWV DQG
ULVNRI&&$DQGiiWKHGLDJQRVLVRI&&$ZDVEDVHGRQ
KLVWRORJLFDO H[DPLQDWLRQ DQG WKH DSSURSULDWH LPDJLQJ
FKDUDFWHULVWLFV7KHH[FOXVLRQFULWHULDZHUHiGXSOLFDWH
DUWLFOHV ZKHUH GXSOLFDWLRQ RFFXUUHG RQO\ RQH RI WKH
)LJXUH)ORZ'LDJUDP6KRZLQJWKH6HOHFWLRQ3URFHVV
IRU$UWLFOHVWREH,QFOXGHGLQWKH6\VWHPDWLF5HYLHZ
$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO
7013
Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Meta-Analysis articles was included; and iiQRQKXPDQUHVHDUFK
Quality assessment of primary studies
$VVHVVPHQW RI 5LVN RI %LDV 52% WKH DVVHVVPHQW
RI52%LQWKHLQFOXGHGVWXGLHVDOORIZKLFKXVHGDQRQ
UDQGRPL]HGUHVHDUFKGHVLJQZDVEDVHGRQWKH&RFKUDQH
ULVN RI ELDV WRRO GHYHORSHG E\ WKH 1RQ5DQGRPL]HG
6WXGLHV0HWKRGV*URXS1560*7KLVWRROH[DPLQHV
VHOHFWLRQELDVDWWULEXWLRQELDVGHWHFWLRQELDVDQGUHSRUWLQJ
ELDV ZLWK WKH DGGLWLRQ RI WKH LQÁXHQFH RI FRQIRXQGLQJ
YDULDEOHV 1RQ5DQGRPLVHG 6WXGLHV 0HWKRGV *URXS
7KH SDUWLFXODU LQVWUXPHQW FKRVHQ IRU HYDOXDWLQJ
WKHVWXGLHVDFFRUGLQJWRWKH52%WRROZDVWKH1HZFDVWOH
2WWDZD 6FDOH 126 IRU DVVHVVLQJ WKH TXDOLW\ RI FDVH
FRQWUROVWXGLHV:HOOVHWDO
'DWD H[WUDFWLRQ DQG PDQDJHPHQW this is an 8-item VFDOHZKLFKFRYHUVWKHDVVHVVPHQWRIFDVHVHOHFWLRQDQG
control selection, study comparability, and exposure. For WKHSXUSRVHRIWKHSUHVHQWUHYLHZWKHVFDOHZDVDGDSWHG
VRWKDWHDFKSULPDU\VWXG\ZDVUDWHGLQWHUPVRID¶ORZ·
¶KLJK·RU¶XQFOHDU·ULVNRIELDVRQHDFKRIWKHHLJKWLWHPV
The adapted scale is reproduced in Table 1. Independent UDWLQJVZHUHPDGHE\6.DQG0/DQGDQ\GLVDJUHHPHQWV
ZHUHUHVROYHGWKURXJKGLVFXVVLRQZLWKWKHWKLUGUHVHDUFKHU
9%5HYLHZ0DQDJHU6RIWZDUHZDVXVHGWRGRXEOHHQWHU
DOOWKHGDWD5HY0DQ
Data analysis
0HDVXUHV RI DVVRFLDWLRQ WKH PDJQLWXGH RI WKH
DVVRFLDWLRQVEHWZHHQ3=4WUHDWPHQWVDQG&&$LQWHUPV
RI3=4XVHFDWHJRUL]HGLQWRWZRGLIIHUHQWJURXSV¶\HV·
RU¶QR·ZHUHSUHVHQWHGLQWKHIRUPRIRGGVUDWLRV25V DQGWKHLUFRQÀGHQFHLQWHUYDOV&,
$VVHVVPHQW RI KHWHURJHQHLW\ KHWHURJHQHLW\ RI WKH
UHVXOWV DFURVV VWXGLHV ZDV DVVHVVHG XVLQJ IRUHVW SORWV
0 25.0 50.0 75.0 100.0
y diagnosed without treatment Newly diagnosed with treatment Persistence or recurrence Remission None Chemotherapy Radiotherapy Concurrent chemoradiation
Table 1. 5LVNRI%LDV52%,WHPV$GDSWHGIURP1HZFDVWOH2WWDZD6FDOH126V
6(/(&7,21 ,VWKH&DVH'HÀQLWLRQ$GHTXDWH" D\HVORZULVNRIELDVHJHOLJLELOLW\FULWHULDRSHUDWLRQDOGHÀQLWLRQ
E\HVKLJKULVNRIELDVHJQRWVWDWHGLQSDUWD
FQRGHVFULSWLRQXQFOHDUULVNRIELDV
5HSUHVHQWDWLYHQHVVRIWKH&DVHV D\HVORZULVNRIELDVHJFRQVHFXWLYHUHSUHVHQWDWLYHVHULHVRIFDVHV
E\HVKLJKULVNRIELDVHJQRWVDWLVI\LQJUHTXLUHPHQWVLQSDUWDRUQRWVWDWHG
FQRGHVFULSWLRQXQFOHDUULVNRIELDV
6HOHFWLRQRI&RQWUROV D\HVORZULVNRIELDVHJFRPPXQLW\FRQWUROV
E\HVKLJKULVNRIELDVHJKRVSLWDOFRQWUROV
FQRGHVFULSWLRQXQFOHDUULVNRIELDV
'HÀQLWLRQRI&RQWUROV D\HVORZULVNRIELDVHJQRKLVWRU\RI&&$
E\HVKLJKULVNRIELDVHJQRPHQWLRQRIKLVWRU\RI&&$
FQRGHVFULSWLRQRIVRXUFHXQFOHDUULVNRIELDV
&203$5$%,/,7< &RPSDUDELOLW\RIFDVHVDQGFRQWUROVRQWKHEDVLVRIWKHGHVLJQRUDQDO\VLV
D\HVORZULVNRIELDV
HJPDWFKLQJFRQVLGHUDWLRQE\DJHPXOWLSOHDQDO\VLVZLWKDJHDGMXVWHG
E\HVKLJKULVNRIELDVHJQRWVWDWHGLQSDUWD
FQRGHVFULSWLRQRIVRXUFHXQFOHDUULVNRIELDV
(;32685( $VFHUWDLQPHQWRIH[SRVXUH D\HVORZULVNRIELDV
VHFXUHUHFRUGHJVXUJLFDOUHFRUGVVWUXFWXUHGLQWHUYLHZZKHUHEOLQGWRFDVHFRQWUROVWDWXV
E\HVKLJKULVNRIELDV
HJLQWHUYLHZHUQRWEOLQGHGWRFDVHFRQWUROVWDWXVZULWWHQVHOIUHSRUWRUPHGLFDOUHFRUGRQO\
FQRGHVFULSWLRQRIVRXUFHXQFOHDUULVNRIELDV
6DPHPHWKRGRIDVFHUWDLQPHQWIRUFDVHVDQGFRQWUROV
D\HVORZULVNRIELDVHJXVHRIDVWUXFWXUHGTXHVWLRQQDLUH
E\HVKLJKULVNRIELDVHJQRWVWDWHGLQSDUWD
FQRGHVFULSWLRQRIVRXUFHXQFOHDUULVNRIELDV
1RQ5HVSRQVHUDWH D\HVORZULVNRIELDVHJVDPHUDWHIRUERWKJURXSV
E\HVKLJKULVNRIELDVHJQRQUHVSRQGHQWVGHVFULEHGUDWHGLIIHUHQWDQGQRGHVLJQDWLRQ
FQRGHVFULSWLRQRIVRXUFHXQFOHDUULVNRIELDV
WKH&RFKUDQ·V4WHVWDQG,2$QXQDFFHSWDEOHGHJUHHRI
inconsistency across the study outcomes was considered WRKDYHRFFXUUHGZKHQ WKHSYDOXHRI WKH&RFKUDQ·V 4
test statistic was <0.10 and I2ZDV!+LJJLQVHWDO
3RROLQJDVVRFLDWLRQDUDQGRPHIIHFWVPRGHOZDVXVHG
WRSRROWKHDVVRFLDWLRQHIIHFWVDFURVVWKHVWXGLHVZKHQWKHUH
ZDVHYLGHQFHRIDQXQDFFHSWDEOHGHJUHHRIKHWHURJHQHLW\
which could not be explained.
Ethnical consideration
7KLVVWXG\ZDVPHWWKHFULWHULDIRUH[HPSWUHYLHZRI
WKH.KRQ.DHQ8QLYHUVLW\(WKLFV&RPPLWWHHIRU+XPDQ
Research.
5HVXOWV
Characteristics of included studies
$WRWDORIVWXGLHVZHUHLQGHQWLÀHGXVLQJWKHVHDUFK
VWUDWHJLHV GHVFULEHG DERYH$IWHU UHDGLQJ WKH WLWOHV
DEVWUDFWV DQG IXOOWH[W DUWLFOHV WKUHH UHOHYDQW VWXGLHV
ZHUHVHOHFWHGIRUGHWDLOHGHYDOXDWLRQ$VXPPDU\RIWKHVH
VWXGLHVLQFOXGLQJGHWDLOVRITXDQWLÀFDWLRQRI3=4XVHLV
provided in Table 2.
Risk of bias (ROB)
7KHUHYLHZDXWKRUVDVVHVVHGWKHTXDOLW\RIWKHWKUHH
VWXGLHVXVLQJWKH52%VFDOH2QHVWXG\ZDVMXGJHGDV
KDYLQJ´XQFOHDUULVNRIELDVµUHJDUGLQJLWVGHÀQLWLRQRI
FRQWUROV1RGHWDLOHGGHÀQLWLRQZDVSURYLGHGDQGFRQWUROV
ZHUHVLPSO\GHVFULEHGDVUDQGRPO\VHOHFWHGVXEMHFWVZKR
had not developed CCA. Furthermore, two studies were DVVHVVHG DV KDYLQJ ´XQFOHDU ULVN RI ELDVµ FRQFHUQLQJ D
ODFNRILQIRUPDWLRQDERXWQRQUHVSRQVHUDWHV)LJXUH
)LJXUH
$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO
7014
)LJXUH5LVNRI%LDV*UDSK5HYLHZ$XWKRUV·-XGJPHQWVDERXW(DFK5LVNRI%LDV,WHP3UHVHQWHGDV3HUFHQWDJHV
Across All Included Studies
)LJXUH 5LVN RI %LDV 6XPPDU\ 5HYLHZ$XWKRUV·
-XGJPHQWVDERXW(DFK5LVNRI%LDV,WHPIRU(DFKRI
the Included Studies
)LJXUH0HWD$QDO\VLV)RUHVW3ORWVRIWKH5HODWLRQVKLS
between PZQ Treatments and CCA
0DLQÀQGLQJ
2QH VWXG\ FDWHJRUL]HG 3=4 XVH LQWR IRXU GLIIHUHQW
JURXSVQHYHUXVHGXVHGRQFHXVHGWZLFHDQGXVHGPRUH
WKDQWZLFH&KHUQUXQJURMDQGIRUWKLVUHDVRQZDV
H[FOXGHGIURPWKHPHWDDQDO\VLV7KHSULPDU\DLPRIWKH
study had been to measure the independent association EHWZHHQXVHRIDOFRKROLFEHYHUDJHVDQG&&$ZKLOHXVHRI
3=4ZDVLQYHVWLJDWHGDVDSRWHQWLDOULVNIDFWRU,QDGGLWLRQ
DOWKRXJK WKH VWXG\ GLG SURYLGH D FOHDU FDVH GHÀQLWLRQ
LQ WHUPV RI WKH 52% VFDOH WKH PHWKRG RI GLDJQRVLV
IRULQFOXVLRQRIPDQ\RIWKHFDVHVFRXOGEHFRQVLGHUHG
XQVDWLVIDFWRU\,QWKHVHOHFWLRQRIFDVHVXVLQJLQIRUPDWLRQ
IURP PHGLFDO UHFRUGV WKH GLDJQRVLV ZDV KLVWRORJLFDOO\
FRQÀUPHGLQRQO\RXWRIVXEMHFWV)RUWKH
UHPDLQLQJWKHGLDJQRVLVZDVPDGHRQWKHEDVLVRID
FRPELQDWLRQRIXOWUDVRXQG&7DQGFOLQLFDOH[DPLQDWLRQV
7KH RWKHU WZR VWXGLHV FDWHJRUL]HG 3=4 XVH LQWR
WZR JURXSV ¶QHYHU XVHG· DQG ¶XVHG· DQG ZHUH DEOH WR
EH LQFOXGHG LQ WKH PHWDDQDO\VLV +RQMR HW DO
3RRPSKDNZDHQHWDO+RZHYHUWKHRXWFRPHRIWKH
PHWDDQDO\VLVVKRZHGWKDWWKHDVVRFLDWLRQEHWZHHQ3=4
WUHDWPHQWVDQG&&$ZDVLQFRQFOXVLYH:KHQWKHUHVXOWV
RI WKH WZR VWXGLHV ZHUH SRROHG XVLQJ D UDQGRP HIIHFWV
PRGHOWKHRYHUDOO25ZDVZLWKD&,RIWR
)LJXUH
Discussion
7KHDLPRIWKLVV\VWHPDWLFUHYLHZZDVWRLQYHVWLJDWH
WKH UHODWLRQVKLS EHWZHHQ 3=4 WUHDWPHQWV DQG &&$ LQ
patients with O viverriniLQIHFWLRQV7KUHHHSLGHPLRORJLFDO
VWXGLHVZHUHIRXQGZKLFKPHWWKHHOLJLELOLW\UHTXLUHPHQWV
IRULQFOXVLRQLQWKHUHYLHZ&KHUQUXQJURM+RQMR
HW DO 3RRPSKDNZDHQ HW DO $OO ZHUH
FDVHFRQWUROVWXGLHV7ZRRIWKHVWXGLHV&KHUQUXQJURM
+RQMRHWDOIRXQGDVWDWLVWLFDOO\VLJQLÀFDQW
DVVRFLDWLRQEHWZHHQ3=4WUHDWPHQWVDQG&&$ZKLOVWWKH
WKLUG3RRPSKDNZDHQHWDOGLGQRW8QIRUWXQDWHO\
RQO\WZR+RQMRHWDO3RRPSKDNZDHQHWDO were able to included in the meta-analysis, and the overall UHVXOW ZDV D QRQVLJQLÀFDQW UHODWLRQVKLS EHWZHHQ 3=4
treatments and CCA.
$ KLVWRORJLFDOO\ FRQILUPHG GLDJQRVLV VKRXOG EH
UHTXLUHG IRU PRVW FDQFHUV ,VDEHO EXW DOO WKUHH
VWXGLHV IDLOHG WR GR WKLV ,Q WKH VWXG\ E\ &KHUQUXQJURM
KLVWRORJLFDO FRQÀUPDWLRQ RI &&$ ZDV REWDLQHG
IRURIWKHFDVHVLQ+RQMRHWDORQO\
RIWKHFDVHGLDJQRVHVZHUHKLVWRORJLFDOO\FRQÀUPHGDQG
LQ 3RRPSKDNZDHQ HW DO WKH SHUFHQWDJH LV RQO\
:LWKRXWKLVWRORJLFDOHYLGHQFHVRPHFDVHVPD\EH
LQFRUUHFWO\GLDJQRVHGZLWKWKHUHVXOWWKDWUHDOH[SRVXUH
GLIIHUHQFHVEHWZHHQFDVHVDQGFRQWUROVDUHGLOXWHGDQG
WKHFKDQFHVRIGHPRQVWUDWLQJDQHIIHFWDUHUHGXFHG7KLV
PD\ DW OHDVW SDUWO\ H[SODLQ WKH DEVHQFH RI VWDWLVWLFDOO\
VLJQLÀFDQW RXWFRPH LQ WKH PHWDDQDO\VLV ,Q DGGLWLRQ
WKHUH DSSHDUHG WR EH D KLJK GHJUHH RI KHWHURJHQHLW\ RU
LQFRQVLVWHQF\RIHIIHFWVDFURVVWKHWZRVWXGLHVLQFOXGHG
in the meta-analysis, and this may have contributed to the QRQVLJQLÀFDQWUHVXOW5HJUHWWDEO\LWZDVQRWSRVVLEOHWR
SLQSRLQWWKHVRXUFHVRIWKLVODFNRIFRQVLVWHQF\GXHWKH
OLPLWHGQXPEHURIVWXGLHV
,Q SUHVHQWLQJ WKH UHVXOWV RI WKH DVVHVVPHQW RI 52%
LQWKHWKUHHLQFOXGHGVWXGLHVWZRÀJXUHVZHUHJHQHUDWHG
$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO
Praziquantel and Cholangiocarcinoma in Patients Infected with Opisthorchis viverrini: A Meta-Analysis XVLQJ5HY0DQ5HY0DQ$52%JUDSKÀJXUHVLOOXVWUDWHVWKHSURSRUWLRQRI
VWXGLHVZLWKHDFKRIWKHDXWKRUV·MXGJPHQWV¶\HV·¶QR·¶XQFOHDU·IRUHDFKHQWU\
LQWKHWRRO,QRQHRIWKHWZRVWXGLHVLQFOXGHGLQWKHPHWDDQDO\VLVWKHUHZDVDQ
´XQFOHDUULVNRIELDVµDULVLQJIURPWKHODFNRIGHÀQLWLRQRIFRQWUROV,QERWKVWXGLHV
LQFOXGHGLQWKHPHWDDQDO\VLVWKHUHZDVDQ´XQFOHDUULVNRIELDVµGXHWRWKHDEVHQFHV
RILQIRUPDWLRQDERXWUHVSRQVHUDWHV7DNHQWRJHWKHUWKHVHULVNVRIELDVUDLVHIXUWKHU
GRXEWVDERXWWKHYDOLGLW\RIWKHRXWFRPHRIWKHPHWDDQDO\VLV1HYHUWKHOHVVWKH
ULVNRIELDVZDVDVVHVVHGDV´ORZµRQVL[RIWKHHLJKWVLWHPVRIWKH52%VFDOHIRU
all three studies included in the review.
7KHUHZDVDWRWDO&&$SDWLHQWVZLWKLQIHFWHGO viverrini in the three Thailand VWXGLHV:HGLGQRWLQFOXGHGVWXGLHVIURPRWKHUFRXQWULHVVXFKDV/DR3HRSOH·V
'HPRFUDWLF 5HSXEOLF /DRV 3'5 &DPERGLD RU 9LHWQDP 7KLV ZDV EHFDXVH
DVRXUVHDUFKRIGDWDEDVHVLQGLFDWHGWKHUHZHUHQRVWXGLHVLQWKHVHQHLJKERULQJ
FRXQWULHVZKLFKVSHFLÀFDOO\LQYHVWLJDWHGDUHODWLRQVKLSEHWZHHQQXPEHURI3=4
WUHDWPHQWVDQG&&$DOWKRXJKWKHUHZHUHDIHZVWXGLHVZKLFKUHSRUWHGGHVFULSWLYH
data about O viverriniDQG&&$&KDLHWDO/HHHWDO'HHWDO
+RZHYHUDVLVJHQHUDOO\NQRZQLQIHFWLRQZLWKO viverrini is endemic in the Lower 0HNRQJUHJLRQ:HWKHUHIRUHQHHGWREHFDXWLRXVDERXWWKHUHSUHVHQWDWLYHQHVVRI
the published articles.
7KHUHZHUHWZRLPSRUWDQWVWUHQJWKVRIWKLVVWXG\)LUVWO\WKLVLVDQDSSURSULDWH
GHVLJQ7KLVLVWKHV\VWHPDWLFUHYLHZRIWKHFXUUHQWO\DYDLODEOHHYLGHQFHZKLFK
ZDVSHUIRUPHGWRLQYHVWLJDWHZKHWKHU3=4WUHDWPHQWVDUHSRVLWLYHO\UHODWHGWRDQ
LQFUHDVHGULVNRI&&$LQSDWLHQWVZLWKO viverrini6HFRQGO\WKHOLWHUDWXUHUHYLHZ
LQFOXGHGDVHDUFKRIWKH(0%$6(0('/,1(3UR4XHVW3XE0HGDQG6&2386
GDWDEDVHVDQGWKHPHWKRGRILGHQWLI\LQJDQGVHOHFWLQJVWXGLHVIRULQFOXVLRQLQWKH
UHYLHZZDVH[SOLFLW7KLVOLPLWHGDQ\ELDVLQWKHFKRLFHRIVWXGLHVIRUUHYLHZDQG
LQFUHDVHGWKHUHOLDELOLW\DQGDFFXUDF\RIWKHFRQFOXVLRQV
7KLVV\VWHPDWLFUHYLHZZDVOLPLWHGE\WKHVFDUFLW\RIVWXGLHVZKLFKZHUHHOLJLEOH
IRULQFOXVLRQLQWKHUHYLHZDQGRQO\RQHVWXG\H[SORUHGIUHTXHQF\RI3=4XVHE\
FDWHJRULVLQJVXEMHFWVLQWRIRXUJURXSQHYHUXVHGXVHGRQFHXVHGWZLFHDQGXVHG
PRUHWKDQWZLFHZKLOHWKHRWKHUWZRVWXGLHVVLPSO\FDWHJRUL]HGVXEMHFWVLQWRWZR
JURXSVQHYHUXVHGDQGXVHG7KHQXPEHURIVWXGLHVLQFOXGHGLQWKHUHYLHZDQG
WKH WRWDO VDPSOH VL]H RI &&$ SDWLHQWV LQIHFWHG ZLWK O viverrini included in the VWXGLHVZHUHQRWODUJHHQRXJKDQGWKLVPD\KDYHZHDNHQHGWKHSRZHUDQGKHQFH
WKHYDOLGLW\RIWKHDQDO\VLV7KHRXWFRPHPD\DOVRKDYHEHHQZHDNHQHGE\WKH
DEVHQFHRIKLVWRORJLFDOO\FRQÀUPHGGLDJQRVHV
,Q FRQFOXVLRQ WKH ÀQGLQJV SURYLGH QR ÀUP HYLGHQFH DV WR ZKHWKHU 3=4
WUHDWPHQWVFRXOGLQFUHDVHWKHULVNRI&&$)XUWKHUUHVHDUFKLVQHHGHGWRIRFXVRQWKH
SULPDU\DLPRIDVVHVVLQJWKHUHODWLRQVKLSEHWZHHQQXPEHURI3=4WUHDWPHQWVDQG
&&$XVLQJGHÀQLWLRQVRIFDVHVDQGFRQWUROVZKLFKDUHDGHTXDWHIRUWKHVDWLVIDFWRU\
PHDVXUHPHQW RI RXWFRPH DQG SURYLGLQJ LQIRUPDWLRQ DERXW UHVSRQVH UDWHV ,Q
SDUWLFXODUDKLVWRORJLFDOO\FRQÀUPHGGLDJQRVLVRI&&$VKRXOGEHDUHTXLUHPHQW
LQIXWXUHVWXGLHV
Acknowledgements
7KHDXWKRUWKDQNVD3URIHVVRU&KRPFKDUN&KDQWUDVDNXO)DFXOW\RI0HGLFLQH
6LULUDM+RVSLWDO0DKLGRO8QLYHUVLW\DQG&HUHERV7KDLODQG/WGWKRVHIXQGHGWKLV
UHVHDUFKE3URIHVVRU5RVV+$QGUHZVDWWKH/LYHU)OXNH &KRODQJLRFDUFLQRPD
5HVHDUFK &HQWUH )DFXOW\ RI 0HGLFLQH ..8 IRU KLV KHOSIXO FRPPHQWV F 0V<XZDGHH3KHWFKDUDDOLEUDULDQZKRKHOSHGLQWKHXVHRIVHDUFKHQJLQHVG
$VVLVWDQW3URIHVVRU3RUMDL3DWWDQLWWXPIRUKHUJXLGDQFHRQWKHXVHRI5HY0DQIRU
FRQGXFWLQJD0HWDDQDO\VLVH3HWHU%UDGVKDZIRUDVVLVWDQFHZLWKWKHFRQWHQW
DQG(QJOLVKODQJXDJHSUHVHQWDWLRQRIWKHPDQXVFULSWDQGI$VVLVWDQW3URIHVVRU
6LULSRUQ.DPVDDUGZKRHQFRXUDJHGWRZRUNRQV\VWHPDWLFUHYLHZV7KLVVWXG\LV
SDUWRIGRFWRUDOGLVVHUWDWLRQDWWKH*UDGXDWH6FKRRO.KRQ.DHQ8QLYHUVLW\7KDLODQG
5HIHUHQFHV
%KDPDUDSUDYDWL19LUUDQXYDWWL9/LYHUGLVHDVHVLQ7KDLODQG$QDQDO\VLVRIOLYHU
biopsies. Am J Gastroenterol, , 267-75.
Table 2. Summary of Study Characteristics According to PZQ Treatments $XWKRUV6WXG\GHVLJQ6HWWLQJ&&$&RQWURO&RPPHQWV n Exposuren Exposure &KHUQUXQJURM3RSXODWLRQEDVHGFDVH²FRQWUROVWXG\.KRQ.DHQ7KDLODQG3=4XVHIRXUGLIIHUHQWJURXSV )UHTXHQF\PDWFKHGE\VH[DQGDJHQHYHUXVHGXVHGRQFHXVHGWZLFHDQGXVHGPRUHWKDQWZLFH +RQMRHWDO3RSXODWLRQEDVHGFDVH²FRQWUROVWXG\1DNKRQ3DKQRPSURYLQFLDOKRVSLWDO7UHDWPHQWZLWK3=4WZRGLIIHUHQWJURXSV1R<HV ,QGLYLGXDOVPDWFKHGE\VH[DJHDQGSODFHRIUHVLGHQFH7KDLODQG² 3RRPSKDNZDHQHWDO 1HVWHGFDVHFRQWUROVWXG\.KRQ.DHQ7KDLODQG+LVWRU\RI3=4XVHWZRGLIIHUHQWJURXSV1R<HV ,QGLYLGXDOVPDWFKHGE\VH[DJH\HDUVDQGVDPHSHULRGRI UHFUXLWPHQWWRWKHFRKRUWPRQWKV
$VLDQ3DFLÀF-RXUQDORI&DQFHU3UHYHQWLRQ9RO
7016
0 25.0 50.0 75.0 100.0
Newly diagnosed without treatment Newly diagnosed with treatment Persistence or recurrence Remission None Chemotherapy Radiotherapy Concurrent chemoradiation
%KXGKLVDZDVGL 9 .KXQWLNHR 1 &KXULQ 6 HW DO
&KRODQJLRFDUFLQRPD([SHULHQFHRI6ULQDJDULQG+RVSLWDO
Srinagarind Med J, 27
&KDURHQVXN/3LQODRU33UDNREZRQJ6HWDO&XUFXPLQ
LQGXFHVDQXFOHDUIDFWRUHU\WKURLGUHODWHGIDFWRUGULYHQ
UHVSRQVH DJDLQVW R[LGDWLYH DQG QLWUDWLYH VWUHVV DIWHU
SUD]LTXDQWHOWUHDWPHQWLQOLYHUÁXNHLQIHFWHGKDPVWHUVInt J Parasitol, 41, 615-26.
&KHUQUXQJURM*5LVNIDFWRUIRUFKRODQJLRFDUFLQRPDD
FDVHFRQWUROVWXG\'RFWRUDO'LVVHUWDWLRQWRWKH)DFXOW\RI
WKH*UDGXDWH6FKRRO<DOH8QLYHUVLW\
&KDL -< +RQJYDQWKRQJ % $ VPDOOVFDOH VXUYH\ RI
LQWHVWLQDO KHOPLQWKLF LQIHFWLRQV DPRQJ WKH UHVLGHQWV QHDU
3DNVH/DRVKorean J Parasitol, 36, 55-8.
'H190XUUHOO.'&RQJ/'HWDO7KHIRRGERUQH
WUHPDWRGH ]RRQRVHV RI 9LHWQDP Southeast Asian J Trop Med Public Health, 34
'HHUDVDPHH60DUWLQ16RQWLSRQJ6HWDO&DQFHULQ
7KDLODQG9RO,,,$5&7HFKQLFDO5HSRUW1R
/\RQ,$5&
GRV 6DQWRV 6LOYD , &DQFHU HSLGHPLRORJ\ 3ULQFLSOHV
DQGPHWKRGV,$5&,QWHUQDWLRQDO$JHQF\IRU5HVHDUFKRQ
&DQFHU/\RQ,QWHUQDWLRQDO$JHQF\IRU5HVHDUFKRQ&DQFHU
*UXQG\:DUU &$QGUHZV 5+ 6LWKLWKDZRUQ 3 HW DO
5DZDWWLWXGHVZHWODQGFXOWXUHVOLIHF\FOHVVRFLRFXOWXUDO
G\QDPLFVUHODWLQJWROpisthorchis viverriniLQWKH0HNRQJ
%DVLQParasitol Int, 61, 65-70.
+DVZHOO(ONLQV 05 0DLULDQJ ( 0DLULDQJ 3 HW DO
&URVVVHFWLRQDOVWXG\RIOpisthorchis viverriniLQIHFWLRQDQG
FKRODQJLRFDUFLQRPDLQFRPPXQLWLHVZLWKLQDKLJKULVNDUHD
in northeast Thailand. Int J Cancer,
+LJJLQV-377KRPSVRQ6*'HHNV--HWDO0HDVXULQJ
inconsistency in meta-analyses. BMJ, 327, 557-60.
+RQMR66ULYDWDQDNXO36ULSOXQJ+HWDO*HQHWLFDQG
HQYLURQPHQWDOGHWHUPLQDQWVRIULVNIRUFKRODQJLRFDUFLQRPD
via Opisthorchis viverrini LQ D GHQVHO\ LQIHVWHG DUHD LQ
1DNKRQ 3KDQRP QRUWKHDVW 7KDLODQG Int J Cancer, 117,
-RQJVXNVXQWLJXO 3 6HPLQDU LQ 3DUDVLWLF 'LVHDVHV
LQ QRUWKHDVW 7KDLODQG .OXQJQDQD 9LWD\D .KRQ .DHQ
7KDLODQG3DUDVLWLFGLVHDVHLQ1RUWKHDVW7KDLODQG
.DHZSLWRRQ 1 .DHZSLWRRQ 6- 3HQJVDD 3
2SLVWKRUFKLDVLV LQ 7KDLODQG UHYLHZ DQG FXUUHQW VWDWXV
World J. Gastroenterol, 14
.KXKDSUHPD7$WWDVDUD36ULSOXQJ+HWDO/LYHUDQG
%LOHGXFWCancer in Thailand, 6
.KXKDSUHPD76ULYDWDQDNXO3$WWDVDUD3HWDO/LYHU
DQG%LOHGXFWCancer in Thailand,
.KXKDSUHPD76ULYDWDQDNXO36ULSOXQJ+HWDO/LYHU
DQG%LOHGXFW&DQFHULQ7KDLODQG
/HH.-%DH<7.LP'+HWDO6WDWXVRILQWHVWLQDO
SDUDVLWHV LQIHFWLRQ DPRQJ SULPDU\ VFKRRO FKLOGUHQ LQ
.DPSRQJFKDP&DPERGLDKorean J Parasitol, 40
1RQ5DQGRPL]HG 6WXGLHV 0HWKRGV *URXS 1560*
The Cochrane Collaboration.
3DUNLQ'06ULYDWDQDNXO3.KODW0HWDO/LYHUFDQFHU
LQ7KDLODQG,$FDVHFRQWUROVWXG\RIFKRODQJLRFDUFLQRPD
Int J Cancer,
3LQODRU 6 0D 1 +LUDNX< HW DO 5HSHDWHG LQIHFWLRQ
with Opisthorchis viverrini LQGXFHV DFFXPXODWLRQ RI
QLWURJXDQLQHDQGR[RGLK\GUR·GHR[\JXDQLQHLQ
WKHELOHGXFWRIKDPVWHUVYLDLQGXFLEOHQLWULFR[LGHV\QWKDVH
Carcinogenesis,
3LQODRU 6 3UDNREZRQJ 6 %RRQPDUV 7 HW DO (IIHFW
RI SUD]LTXDQWHO WUHDWPHQW RQ WKH H[SUHVVLRQ RI PDWUL[
0HWDOORSURWHLQDVHV LQ UHODWLRQ WR WLVVXH UHVRUSWLRQ GXULQJ
ÀEURVLV LQ KDPVWHUV ZLWK DFXWH DQG FKURQLF Opisthorchis
viverriniLQIHFWLRQActa Tropica, 111
3RRPSKDNZDHQ.3URPWKHW6.DPVDDUG6HWDO5LVN
)DFWRUVIRU&KRODQJLRFDUFLQRPDLQ.KRQ.KDHQ7KDLODQG
$ 1HVWHG &DVH&RQWURO 6WXG\ Asian Pac J Cancer Prev, 10, 251-7.
5HY0DQ7KH&RFKUDQH&ROODERUDWLRQ5HYLHZ0DQDJHU
5HY0DQ&RSHQKDJHQ7KH1RUGLF&RFKUDQH&HQWUH
The Cochrane Collaboration.
6LWKLWKDZRUQ 3 &XUUHQW 5ROHV RI /LYHU )OXNH RQ
2FFXUUHQFH RI &KRODQJLRFDUFLQRPD Srinagarind Med J, 20
6LWKLWKDZRUQ 3 +DVZHOO(ONLQV 0 (SLGHPLRORJ\ RI
Opisthorchis viverrini. Acta Trop,
6ULSD%%HWKRQ\-06LWKLWKDZRUQ3HWDO2SLVWKRUFKLDVLV
DQG2SLVWKRUFKLVDVVRFLDWHGFKRODQJLRFDUFLQRPDLQ7KDLODQG
and Laos. Acta Trop, 120, 158-68.
6ULSD%.DHZNHV66LWKLWKDZRUQ3HWDO/LYHUÁXNH
LQGXFHVFKRODQJLRFDUFLQRPD PLoS Med, 4, 201.
6ULSD % <RQJYDQLW 3 3DLURMNXO & (WLRORJ\ DQG
SDWKRJHQHVLV RI FKRODQJLRFDUFLQRPD LQWURGXFWLRQ WR WKH
DVVRFLDWLRQZLWKOLYHUÁXNHLQIHFWLRQSrinagarind Med J, 20
6ULSOXQJ + 6RQWLSRQJ 6 0DUWLQ 1 HW DO &DQFHU LQ
7KDLODQG9RO,,,%DQJNRN%DQJNRN0HGLFDO
Publisher.
7KDPDYLW:%KDPDUDSUDYDWL16DKDSKRQJ6HWDO(IIHFWV
RIGLPHWK\OQLWURVDPLQHRQLQGXFWLRQRIFKRODQJLRFDUFLQRPD
in Opisthorchis viverriniLQIHFWHG6\ULDQJROGHQKDPVWHUV
Cancer Res,
8SDWKDP(69L\DQDQW9%URFNHOPDQ:<HWDO5DWH
RI UHLQIHFWLRQ E\ Opisthorchis viverrini in an endemic QRUWKHDVW 7KDL FRPPXQLW\ DIWHU FKHPRWKHUDS\ Int J Parasitol,
9DWDQDVDSW 9 0DUWLQ 1 6ULSOXQJ + HW DO &DQFHU LQ
7KDLODQG ,$5& 7HFKQLFDO 5HSRUW 1R
Lyon, IARC.
:HOOV*$6KHD%2·&RQQHOO'HWDO7KH1HZFDVWOH
2WWDZD 6FDOH 126 IRU DVVHVVLQJ WKH TXDOLW\ RI
nonrandomised studies in meta-analyses.
:+2&RQWURORIIRRGERUQHWUHPDWRGHLQIHFWLRQV5HSRUW
RID:+26WXG\*URXSWorld Health Organ Tech Rep Ser,
, 1-157.